Therefore, to characterize early tumorigenesis from tumor-prone Krt5+ foregut basal progenitors and to determine their relative tumor susceptibility, we used low-dose tamoxifen treatment (1 day of 0.2 mg tamoxifen by i.p. injection) and analyzed the results (Fig. 1d). The gene discussed is KRT5; the disease is neoplasm.